Jeong JM - Search Results

1

The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model.

Chung JK, Chang YS, Lee YJ, Kim YJ, Jeong JM, Lee DS, Jang JJ, Lee MC. Chung JK, et al. Among authors: jeong jm. Ann Nucl Med. 1999 Oct;13(5):303-8. doi: 10.1007/BF03164868. Ann Nucl Med. 1999. PMID: 10582799

2

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC. Chung JK, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82. doi: 10.1007/s00259-001-0690-4. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926379

3

Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.

Jeong HJ, Chung JK, Kim YK, Kim CY, Kim DG, Jeong JM, Lee DS, Jung HW, Lee MC. Jeong HJ, et al. Among authors: jeong jm. J Nucl Med. 2002 Nov;43(11):1432-7. J Nucl Med. 2002. PMID: 12411544 Free article.

4

[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.

Kim S, Chung JK, Kang SB, Kim MH, Jeong JM, Lee DS, Lee MC. Kim S, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):196-201. doi: 10.1007/s00259-003-1367-y. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129701 Clinical Trial.

5

Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.

Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Kang WJ, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):202-7. doi: 10.1007/s00259-003-1368-x. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129702 Clinical Trial.

6

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC. Kim S, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):52-9. doi: 10.1007/s00259-004-1598-6. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309332

7

Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.

Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC. Kang JH, et al. Among authors: jeong jm. J Nucl Med. 2004 Sep;45(9):1571-6. J Nucl Med. 2004. PMID: 15347726 Free article.

8

Biological properties of 2'-[18F]fluoroflumazenil for central benzodiazepine receptor imaging.

Chang YS, Jeong JM, Yoon YH, Kang WJ, Lee SJ, Lee DS, Chung JK, Lee MC. Chang YS, et al. Among authors: jeong jm. Nucl Med Biol. 2005 Apr;32(3):263-8. doi: 10.1016/j.nucmedbio.2004.12.004. Nucl Med Biol. 2005. PMID: 15820761

9

Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.

Choi MY, Lee KM, Chung JK, Lee DS, Jeong JM, Park JG, Kim JH, Lee MC. Choi MY, et al. Among authors: jeong jm. Ann Nucl Med. 2005 Apr;19(2):123-9. doi: 10.1007/BF03027391. Ann Nucl Med. 2005. PMID: 15909492

10

The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients.

Choi MY, Chung JK, Lee HY, So Y, Park DJ, Jeong JM, Lee DS, Lee MC, Cho BY. Choi MY, et al. Among authors: jeong jm. Ann Nucl Med. 2006 Oct;20(8):547-52. doi: 10.1007/BF03026819. Ann Nucl Med. 2006. PMID: 17134022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters